Cascader completes a seed funding round led by Topcon Healthcare to advance its ophthalmic artificial intelligence platform. The capital will support the transition of AI technologies into clinical use.
Round Type
Seed
United KingdomBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth DiagnosticsInvestors
Description
Cascader, a medical technology company based in the United Kingdom, has completed a seed funding round to advance its ophthalmic artificial intelligence platform. The funding round was led by Topcon Healthcare, which has supported the company since its inception. The capital will help transition its AI technologies into clinical use and support the progression of its initial products toward market launch. Cascader specializes in developing AI tools for the early detection and management of eye diseases.
Quick answer
Cascader raised an undisclosed amount in a Seed round, dated September 23, 2026. Investors: Topcon Healthcare. Cascader is based in United Kingdom.
- How much did Cascader raise?
- Cascader raised an undisclosed amount in a Seed round on September 23, 2026.
- Who invested in Cascader?
- Topcon Healthcare is named as investors in this round.
- What does Cascader do?
- Cascader is a medical technology company focused on developing artificial intelligence tools for the early detection and management of eye diseases.
- Where is Cascader based and how big is it?
- Cascader is based in United Kingdom. Fundz records about 201 employees.
- Who are the decision-makers at Cascader?
- Fundz holds 1 contact at Cascader, including the Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Cascader that raised within 45 days of this round, from Fundz verified event records.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
- Coherence Neuro raised $45M (Series A) on October 22, 2026.
- Scarlet raised $50M (Series B) on October 12, 2026.
- Positron raised $875M (Series C) on September 10, 2026.
Who to call at Cascader, and when
A new round usually means Cascader is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cascader raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cascader, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cascader. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cascader raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cascader raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.